FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223528612> ?p ?o ?g. }

• W4223528612 endingPage "562" @default.
• W4223528612 startingPage "562" @default.
• W4223528612 abstract "Proprotein convertase subtilisin/kexin type-9 (PCSK9) is a key regulator of low-density lipoprotein (LDL) metabolism involved in the degradation of the low-density lipoprotein receptor (LDLR) through complex mechanisms. The PCSK9 plasma levels change according to lipid lowering therapy (LLT). Few data exist regarding the role of PCSK9 in vascular damage. We aimed to evaluate the impact of PCSK9 plasma levels on pulse wave velocity (PWV) and the effect of PCSK9 inhibitors (PCSK9-i) on circulating PCSK9 and PWV in a cohort of heterozygous familial hypercholesterolemia (HeFH) subjects. In a previous step, HeFH patients were enrolled and LLT was prescribed according to guidelines. Biochemical analyses and PWV assessment were performed at baseline (T0), after 6 months of high-efficacy statin plus ezetimibe (T1) and after 6 months of PCSK9-i (T2). The PCSK9 levels were evaluated in 26 selected HeFH subjects at the three time points and 26 healthy subjects served as controls for the reference value for PCSK9 plasma levels. The PWV values decreased at each time point in HeFH subjects after LLT starting (8.61 ± 2.4 m/s, −8.7%; p < 0.001 vs. baseline at T1, and 7.9 ± 2.1 m/s, −9.3%; p < 0.001 vs. both T1 and baseline) and it was correlated to PCSK9 (r = 0.411, p = 0.03). The PCSK9 levels increased on statin/EZE therapy (+42.8% at T1) while it decreased after PCSK9-i was started (−34.4% at T2). We noted a significant relationship between PCSK9 levels and PWV changes at T1 and T2. In conclusion, PCSK9 levels were associated with baseline PWV values in HeFH subjects; moreover, we found that PCSK9 level variations seemed to be correlated with PWV changes on LLT. A longer observation time and wider sample size are needed to assess the potential role of PCSK9 plasma levels on the vascular function and remodelling, and to clarify the effects of PCSK9-i in these pathways." @default.
• W4223528612 created "2022-04-15" @default.
• W4223528612 creator A5011482278 @default.
• W4223528612 creator A5026694842 @default.
• W4223528612 creator A5035898512 @default.
• W4223528612 creator A5040457683 @default.
• W4223528612 creator A5051667347 @default.
• W4223528612 creator A5054429253 @default.
• W4223528612 creator A5058571697 @default.
• W4223528612 creator A5059284377 @default.
• W4223528612 creator A5078087305 @default.
• W4223528612 creator A5081405968 @default.
• W4223528612 creator A5083690016 @default.
• W4223528612 creator A5087271401 @default.
• W4223528612 date "2022-04-09" @default.
• W4223528612 modified "2023-10-01" @default.
• W4223528612 title "PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy" @default.
• W4223528612 cites W1870863005 @default.
• W4223528612 cites W1964641521 @default.
• W4223528612 cites W2020034972 @default.
• W4223528612 cites W2025130216 @default.
• W4223528612 cites W2028074615 @default.
• W4223528612 cites W2033556017 @default.
• W4223528612 cites W2043461445 @default.
• W4223528612 cites W2053653961 @default.
• W4223528612 cites W2057479072 @default.
• W4223528612 cites W2058573028 @default.
• W4223528612 cites W2063025601 @default.
• W4223528612 cites W2076648603 @default.
• W4223528612 cites W2088998164 @default.
• W4223528612 cites W2094941678 @default.
• W4223528612 cites W2099654648 @default.
• W4223528612 cites W2102015915 @default.
• W4223528612 cites W2119708151 @default.
• W4223528612 cites W2126229169 @default.
• W4223528612 cites W2157115489 @default.
• W4223528612 cites W2160761735 @default.
• W4223528612 cites W2196906371 @default.
• W4223528612 cites W2294569099 @default.
• W4223528612 cites W2346825268 @default.
• W4223528612 cites W2501649131 @default.
• W4223528612 cites W2564137254 @default.
• W4223528612 cites W2573169027 @default.
• W4223528612 cites W2594072057 @default.
• W4223528612 cites W2610355229 @default.
• W4223528612 cites W2625181578 @default.
• W4223528612 cites W2743198652 @default.
• W4223528612 cites W2747847803 @default.
• W4223528612 cites W2775439948 @default.
• W4223528612 cites W2807576650 @default.
• W4223528612 cites W2807631284 @default.
• W4223528612 cites W2892662764 @default.
• W4223528612 cites W2900446046 @default.
• W4223528612 cites W2923811375 @default.
• W4223528612 cites W2937069950 @default.
• W4223528612 cites W2953804067 @default.
• W4223528612 cites W2960913366 @default.
• W4223528612 cites W2980576252 @default.
• W4223528612 cites W3000201211 @default.
• W4223528612 cites W3005376769 @default.
• W4223528612 cites W3013984418 @default.
• W4223528612 cites W3088068966 @default.
• W4223528612 cites W3092976149 @default.
• W4223528612 cites W3098480551 @default.
• W4223528612 cites W3183857127 @default.
• W4223528612 cites W3195772185 @default.
• W4223528612 cites W4205447903 @default.
• W4223528612 cites W4225689455 @default.
• W4223528612 cites W4812454 @default.
• W4223528612 doi "https://doi.org/10.3390/biom12040562" @default.
• W4223528612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35454151" @default.
• W4223528612 hasPublicationYear "2022" @default.
• W4223528612 type Work @default.
• W4223528612 citedByCount "10" @default.
• W4223528612 countsByYear W42235286122022 @default.
• W4223528612 countsByYear W42235286122023 @default.
• W4223528612 crossrefType "journal-article" @default.
• W4223528612 hasAuthorship W4223528612A5011482278 @default.
• W4223528612 hasAuthorship W4223528612A5026694842 @default.
• W4223528612 hasAuthorship W4223528612A5035898512 @default.
• W4223528612 hasAuthorship W4223528612A5040457683 @default.
• W4223528612 hasAuthorship W4223528612A5051667347 @default.
• W4223528612 hasAuthorship W4223528612A5054429253 @default.
• W4223528612 hasAuthorship W4223528612A5058571697 @default.
• W4223528612 hasAuthorship W4223528612A5059284377 @default.
• W4223528612 hasAuthorship W4223528612A5078087305 @default.
• W4223528612 hasAuthorship W4223528612A5081405968 @default.
• W4223528612 hasAuthorship W4223528612A5083690016 @default.
• W4223528612 hasAuthorship W4223528612A5087271401 @default.
• W4223528612 hasBestOaLocation W42235286121 @default.
• W4223528612 hasConcept C126322002 @default.
• W4223528612 hasConcept C134018914 @default.
• W4223528612 hasConcept C164705383 @default.
• W4223528612 hasConcept C2776839432 @default.
• W4223528612 hasConcept C2778163477 @default.
• W4223528612 hasConcept C2778319312 @default.
• W4223528612 hasConcept C2778657065 @default.
• W4223528612 hasConcept C2778849439 @default.

• next